Insider Trading activities of Aldeyra Therapeutics, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Aldeyra Therapeutics, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Aldeyra Therapeutics, Inc. since year 2005. Table 2 shows the detailed insider transactions of Aldeyra Therapeutics, Inc. since 2005. The reporting company's ticker symbol is ALDX. The reporting company's CIK number is 1341235.
The total value of stock buying since 2005 is $11,994,784.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $1,000,224.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Aldeyra Therapeutics, Inc. (ALDX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-09 200,000 $1,450,000 0 $0 0 $0
2017-06 296,007 $1,361,632 0 $0 0 $0
2017-02 927,469 $4,173,609 0 $0 0 $0
2016-05 700,000 $3,500,000 0 $0 0 $0
2015-10 150,265 $969,537 0 $0 0 $0
2014-08 4,000 $15,006 0 $0 0 $0
2014-05 65,625 $525,000 0 $0 193,842 $1,000,224

Table 2. Detailed insider stock purchases, sales, and option exercises of Aldeyra Therapeutics, Inc. insiders (ALDX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-09-19 Edelman Joseph (10% Owner) Buy 200,000 7.25 1,450,000
2017-06-30 Edelman Joseph (10% Owner) Buy 296,007 4.60 1,361,632
2017-02-17 Bronstein Ben (Director) Buy 4,444 4.50 19,998
2017-02-17 Brady Todd C (President and CEO) Buy 22,223 4.50 100,003
2017-02-17 Tulipano Stephen J (Chief Financial Officer) Buy 3,333 4.50 14,998
2017-02-17 Joyce Martin Joseph (Director) Buy 4,444 4.50 19,998
2017-02-14 Perceptive Life Sciences Master Fund Ltd Buy 893,025 4.50 4,018,612
2016-05-26 Perceptive Life Sciences Master Fund Ltd Buy 700,000 5.00 3,500,000
2015-10-28 Perceptive Life Sciences Master Fund Ltd Buy 45,100 6.50 293,150
2015-10-26 Perceptive Life Sciences Master Fund Ltd Buy 50,000 6.46 323,150
2015-10-22 Perceptive Life Sciences Master Fund Ltd Buy 18,020 6.47 116,661
2015-10-20 Perceptive Life Sciences Master Fund Ltd Buy 37,145 6.37 236,576
2014-08-07 Joyce Martin Joseph (Director) Buy 1,000 3.95 3,948
2014-08-06 Clarke C. Boyd (Director) Buy 3,000 3.69 11,058
2014-05-07 Bronstein Ben (Director) Buy 12,500 8.00 100,000
2014-05-07 Walker Neal (Director) Buy 6,250 8.00 50,000
2014-05-07 Clarke C. Boyd (Director) Buy 12,500 8.00 100,000
2014-05-07 Brady Todd C (President and CEO) Buy 12,500 8.00 100,000
2014-05-07 Joyce Martin Joseph (Director) Buy 12,500 8.00 100,000
2014-05-07 Phillips Gary M. (Director) Buy 9,375 8.00 75,000
2014-05-01 Vitullo Nicole (10% Owner) Option Ex 121,152 5.16 625,144
2014-05-01 Johnson & Johnson Development Corp Et Al (10% Owner) Option Ex 72,690 5.16 375,080

Insider trading activities including stock purchases, stock sales, and option exercises of ALDX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Aldeyra Therapeutics, Inc. (symbol ALDX, CIK number 1341235) see the Securities and Exchange Commission (SEC) website.